DA32 Life Science Tech Acquisition Corp. (DALS)
NASDAQ: DALS · IEX Real-Time Price · USD
9.67
+0.01 (0.10%)
Jun 24, 2022 1:52 PM EDT - Market closed
0.10%
(1D)
| Market Cap | 248.04M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -571,294 |
| Shares Out | 25.65M |
| EPS (ttm) | -0.02 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 55,200 |
| Open | 9.67 |
| Previous Close | 9.66 |
| Day's Range | 9.67 - 9.67 |
| 52-Week Range | 9.58 - 10.26 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About DALS
DA32 Life Science Tech Acquisition Corp. does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. The company intends to identify business combination targets in the biotechnology and life science infrastructure sectors. DA32 Life Science Tech Acquisition Corp. was incorporated in 2021 and is based in New York, New York. [Read more...]
Industry
Blank Check / SPAC
IPO Date
Jul 28, 2021
Employees
2,021
Stock Exchange
NASDAQ
Ticker Symbol
DALS
News
DA32 Life Science Tech Acquisition Corp., Sponsored by Deerfield, Arch Venture Partners and Section 32, Announces Pri...
NEW YORK--(BUSINESS WIRE)--DA32 Life Science Tech Acquisition Corp. (the “Company”) announced today the pricing of its initial public offering of 20,000,000 shares of Class A common stock at a price of ...